Initial administrative charges to#1 pre-clin TOX study of drug DEV for cancer patients HHSN261201600019I DTP-16-044 TPB

Ended Awarded Jul 6, 2016 Last action Jun 16, 2023

Contract number: HHSN26100001
Awardee: University Of Illinois UEI Y8CWNJRCNN91
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $149

Award facts

Opportunity: N02CM4700142 Solicitation number

Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
Contract value 100% obligated: $149.00 Current and potential, with all options
Completion date 100% complete: Sep 30, 2016 Current and potential, with all options
NAICS code: 541690 Other Scientific and Technical Consulting Services
PSC: R499 Support- Professional: Other
Set-aside: No set-aside
Competition: Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
Pricing: Firm Fixed Price
Place of performance: Bristol, IL 60512, USA
Legislative mandates: Service Contract Act FAR subpart 22.10

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Other Administrative Action P00003	$0	Jun 16, 2023
Funding Only Action P00002 · To#1 pre-clin TOX study of drug DEV for cancer patients HHSN261201600019I DTP-16-044 TPB	-$1,351	Jun 28, 2021
Other Administrative Action 1	$0	Jul 29, 2016
Original award	$1,500	Jul 6, 2016

HHSN26100001 was awarded to University Of Illinois by National Cancer Institute (National Institutes of Health) on July 6, 2016.

The government has obligated $149 on HHSN26100001.

Yes. HHSN26100001 is a delivery order under HHSN261201600019I, an indefinite delivery contract, on Toxicology of Drugs Developed for Cancer Patients.

The extent of competition for HHSN26100001 was full and open competition. The government received 5 offers.

On GovTribe

Try for free Login